Chemical Formula: C17H16N2O3
Chemical Formula C17H16N2O3
Found 39 metabolite its formula value is C17H16N2O3
10-Acetoxy-10,11-dihydro-5h-dibenz[b,f]azepine-5-carboxamide
9-(Acetyloxy)-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaene-2-carboximidate
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D049990 - Membrane Transport Modulators
3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone
3-{4-methyl-2-[(2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
Ethyl 5-(benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylate
Ethyl 5-(benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylate
1H-Indazole-3-carboxylic acid, 6-(phenylmethoxy)-, ethyl ester
1H-Indazole-3-carboxylic acid, 6-(phenylmethoxy)-, ethyl ester
8-BENZYLOXY-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER
8-BENZYLOXY-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER
Eslicarbazepine acetate
Eslicarbazepine acetate
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D049990 - Membrane Transport Modulators
4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol
4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, butyl ester
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, butyl ester
3-[4-methyl-2-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
3-[4-methyl-2-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
N-(2,3-dihydro-1H-inden-5-yl)-2-methyl-3-nitrobenzamide
N-(2,3-dihydro-1H-inden-5-yl)-2-methyl-3-nitrobenzamide
2-[3-(3-Methoxyphenyl)-1-indazolyl]acetic acid methyl ester
2-[3-(3-Methoxyphenyl)-1-indazolyl]acetic acid methyl ester
4-Methoxy-6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-1-cyclohexa-2,4-dienone
4-Methoxy-6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-1-cyclohexa-2,4-dienone
N-(1-cyanocyclohexyl)-2-oxo-1-benzopyran-3-carboxamide
N-(1-cyanocyclohexyl)-2-oxo-1-benzopyran-3-carboxamide
4,9-dihydroxy-1-(3-methylbut-2-en-1-yl)phenazin-5-ium-5-olate
4,9-dihydroxy-1-(3-methylbut-2-en-1-yl)phenazin-5-ium-5-olate
4-methoxy-2-methyl-1,2,3,4-tetrahydro-10-oxa-1,5-diazatetraphen-12-one
4-methoxy-2-methyl-1,2,3,4-tetrahydro-10-oxa-1,5-diazatetraphen-12-one
3-hydroxy-2-(1-hydroxyethyl)-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
3-hydroxy-2-(1-hydroxyethyl)-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
2-hydroxy-8-methoxy-3-(2-phenylethyl)quinazolin-4-one
2-hydroxy-8-methoxy-3-(2-phenylethyl)quinazolin-4-one
(3s)-2-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-methyl-3h-1,4-benzodiazepin-5-one
(3s)-2-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-methyl-3h-1,4-benzodiazepin-5-one
2-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-methyl-3h-1,4-benzodiazepin-5-one
2-hydroxy-3-[(4-hydroxyphenyl)methyl]-4-methyl-3h-1,4-benzodiazepin-5-one
3-hydroxy-2-[(1r)-1-hydroxyethyl]-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
3-hydroxy-2-[(1r)-1-hydroxyethyl]-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
(2r,4s)-4-methoxy-2-methyl-1,2,3,4-tetrahydro-10-oxa-1,5-diazatetraphen-12-one
(2r,4s)-4-methoxy-2-methyl-1,2,3,4-tetrahydro-10-oxa-1,5-diazatetraphen-12-one
